Related Experiment Video
Updated: Sep 26, 2026
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Painting with a molecular brush: genomic/proteomic interfacing to define the drug action profile of novel solid-tumor
Alexander Nakeff1, Nisha Sahay, Mike Pisano
1Drug Discovery and Development Program, Josephine Ford Cancer Center, Henry Ford Health System, Detroit, Michigan 48202, USA.
Abstract:
XK469 is an investigational anticancer agent that exhibits antiproliferative activity in tumor-bearing animal models. We examined the drug-action profile of this agent at the molecular level regarding alterations induced in gene expression and proteins in HCT-116 human colon adenocarcinoma cells. We used a unique cDNA microarray (GeneMap(TM) Cancerarray) comprising 1152 human tumor-related genes and 2-D gel electrophoresis, respectively, following a 24-hour exposure to a drug concentration that killed a two-log fraction of HCT-116 clonogenic cells. Functional gene cluster profile (FGCP) analysis of the 71 out of 1152 genes that displayed a >2-fold increase or decrease in expression (over untreated control) identified a drug-specific involvement of the MAPK signal transduction pathway. MAPK signaling together with the involvement of ubiquitin proteins from 2-D gel electrophoresis suggest a novel drug-action profile at the molecular level for the in vitro antiproliferative activity of XK469.
Insights
The investigational anticancer agent XK469 shows antiproliferative effects by impacting the MAPK signaling pathway and ubiquitin proteins in colon cancer cells.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- XK469 is an investigational anticancer agent with demonstrated antiproliferative activity in preclinical animal models.
- Understanding the molecular mechanisms of novel anticancer agents is crucial for drug development.
Purpose of the Study:
- To elucidate the molecular drug-action profile of XK469 at the gene and protein expression levels.
- To investigate the impact of XK469 on HCT-116 human colon adenocarcinoma cells.
Main Methods:
- Utilized a cDNA microarray (GeneMap(TM) Cancerarray) with 1152 human tumor-related genes.
- Employed 2-D gel electrophoresis to analyze protein alterations.
- Exposed HCT-116 cells to XK469 for 24 hours at a dose lethal to a two-log fraction of clonogenic cells.
Main Results:
- Functional Gene Cluster Profile (FGCP) analysis identified 71 genes with >2-fold expression changes.
- A significant drug-specific involvement of the Mitogen-Activated Protein Kinase (MAPK) signal transduction pathway was observed.
- 2-D gel electrophoresis indicated alterations in ubiquitin proteins.
Conclusions:
- The study suggests a novel molecular drug-action profile for XK469's in vitro antiproliferative activity.
- MAPK signaling and ubiquitin protein involvement are key components of XK469's mechanism of action in colon cancer cells.
